(Q38375684)

2 September 2017

1 reference

title

Potential market for novel tuberculosis diagnostics: worth the investment? (English)

1 reference

2 September 2017

1 reference

Madhukar Pai

5

0 references

Claudia Denkinger

series ordinal

2

object named as

Claudia M Denkinger

1 reference

2 September 2017

Sandra V Kik

1

1 reference

2 September 2017

Carole Jefferson

series ordinal

3

1 reference

2 September 2017

Janet Ginnard

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 2015

1 reference

Journal of Infectious Diseases

2 September 2017

published in

1 reference

2 September 2017

volume

211 Suppl 2

1 reference

2 September 2017

page(s)

S58-66

1 reference

Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Defining the needs for next generation assays for tuberculosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Diagnostics for tuberculosis: what test developers want to know

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Market assessment of tuberculosis diagnostics in Brazil in 2012

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Market assessment of tuberculosis diagnostics in South Africa, 2012-2013.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Costs of novel tuberculosis diagnostics--will countries be able to afford it?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: a decision analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Developing and interpreting models to improve diagnostics in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Alignment of new tuberculosis drug regimens and drug susceptibility testing: a framework for action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

Tuberculosis diagnostics: which target product profiles should be prioritised?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FINFDIS%2FJIU817

21 January 2018

Identifiers

DOI

10.1093/INFDIS/JIU817

1 reference

release_ph6mvkck7rgnfau4i3zbozsdey

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ph6mvkck7rgnfau4i3zbozsdey

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference